| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Selling, general and administrative expenses | 1,015,733 | |||
| Research and development expenses | 238,612 | |||
| Total operating expenses | 1,254,345 | |||
| Operating loss | -1,254,345 | |||
| Interest income | 1,409 | |||
| Interest expense | 275,665 | |||
| Loss on debt settlements | 0 | |||
| Total other expense, net | -274,256 | |||
| Loss before income taxes | -1,528,601 | |||
| Income tax expense | 0 | |||
| Net loss | -1,528,601 | |||
| Deemed dividends on series c, d and h preferred stock | 2,158,161 | |||
| Net loss attributable to common shareholders | -3,686,762 | |||
| Basic and diluted loss per share | -0.55 | |||
| Weighted average shares of common stock outstanding- basic and diluted | 6,716,252 | |||
KNOW LABS, INC. (KNW)
KNOW LABS, INC. (KNW)